NCT06800664Recruiting
Home-based Self-sampling for Cervical Cancer Prevention Education Intervention in Ghana
The Impact of an Evidence-Based, Behavioral Cervical Cancer Screening Intervention Among Women Living With HIV in Ghana (HOPE-inG): A Type 2 Hybrid Effectiveness Implementation Trial
Source: ClinicalTrials.gov · Last updated 1 Jul 2026
Brief summary (registry, in English)
The investigators propose to develop and/or adapt implementation strategies and a structured implementation plan to translate the HOPE intervention into existing healthcare practice in Ghana. These "implementation support strategies (ISS)" are implementation strategies relevant to implementation support, which is concerned with moving (implementation) research into (implementation) practice. The ultimate goal is to facilitate health system adoption and sustainment.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 1500 (estimated)
- First submitted
- 12 Dec 2024
- Start date
- 11 Nov 2025
- Primary completion date
- Nov 2028
- Lead sponsor
- Baylor University
- Diseases
- HIV, Cervical cancer
- NCT number
- NCT06800664
What you commit to
- Study type: Interventional
- Planned participants: 1500
- From 11 Nov 2025 to the primary completion date, Nov 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Women will be excluded if they are pregnant or have had a hysterectomy.
- WLWH who have a cervix are the main target population to develop the HOPE toolkit.
- Women who are below 25 and those who are above 65 years will be excluded.
Who the study is looking for
- General criteria
- ability to give consent per Institutional Review Board stipulations
- residing in the Central Region
- having no medical characteristics that would interfere with the ability to participate fully
- the willingness to participate in this study.
- (a) Healthcare provider eligibility: Inclusion criteria include an individual (no gender restrictions) who
- possesses healthcare qualifications (i.e., patient navigators, physicians, nurses, health facility management),
- works at the HIV health facility at study sites,
- is ≥18 years old. (b) Eligibility for women living with HIV (Patients)
- identified female at birth) who
- are living with HIV between 25 and 65 years old (age consistent with WHO CC screening guidelines)
- have never had CC screening (Pap or HPV test),
- have not had a screening for the past 5 years
Age in the registry: 25 years to 65 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Cape Coast Coordinator of this site? Confirm its status | Cape Coast | Ghana | Recruiting |
Related publications
- Determinants and Strategies for Implementation of the HOPE Self-Sampling Cervical Screening Intervention for Women Living with HIV in Ghana: A Context Assessment and Implementation Mapping Study.Res Sq · 2026 · PMID 42818955
- HOme-based self-sampling for cervical cancer prevention education among women living with HIV in Ghana (HOPE-inG): study protocol for a cluster-randomized type 2 hybrid effectiveness implementation trial.BMC Public Health · 2026 · PMID 41888748
This page is information, not medical advice. Discuss any trial with your doctor.